Pretargeted immunoscintigraphy in patients with medullary thyroid carcinoma

British Journal of Cancer

Volumn 74, Issue 5, 1996, Pages 825-831

  Magnani, P ^b   Paganelli, G ^a,b   Songini, C ^b   Samuel, A ^b   Sudati, F ^b   Siccardi, A G ^b   Fazio, F ^b,c  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Avidin biotin; Medullary thyroid carcinoma; Monoclonal antibody

Indexed keywords

AVIDIN; BIOTIN; CALCITONIN; CARCINOEMBRYONIC ANTIBODY; CHROMOGRANIN A; INDIUM 111; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOLOGY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; IMMUNOSCINTIGRAPHY; ISOTOPE LABELING; LYMPH NODE; MALE; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA; TUMOR LOCALIZATION;

EID: 0029758041     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.443     Document Type: Article

References (53)

1. ADAMS BK, FATAAR A, BYRNL MJ, LEVIT NS AND MATLEY PJ. (1990). Pentavalent technetium-99m (V) DMSA uptake in a patient with Sipple's syndrome. J. Nucl. Med., 31, 106 108.
2. ARNSTEIN NB, JUNI JE, SISSON JC, LLOYD RV AND THOMPSON NW. (1986). Recurrent medullary carcinoma of the thyroid demonstrated by thallium-201 scintigraphy. J. Nucl. Mad., 27, 1564-1568.
3. BAULIEU JL, GIULLOTEAU D, DELISLE MJ, PERDRISOT R, GARDET P, DELEPINE N, BAULIEU F, DUPONT JL, TALBOT JN, COUTRIS G AND CALMETTES C. (1987). Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study. Cancer, 60, 2189-2194.
4. BERCHE C, MACH JP AND LUMBROSO JD. (1982). Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancer: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Br. Med. J., 285, 1447-1451.
5. BRUNT LM AND WELLS SA. (1987). Advances in the diagnosis and treatment of medullary thyroid carcinoma. Emdocrinol. Surg., 67, 263-279.
6. 2 fragments of anti-CEA monoclonal antibody. Cancer Detect. Prev., 10, 335 345.
7. CLARKE SEM, LAZARUS C, MISTRY R AND MAISKY MN. (1987). The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid. Br. J. Rad., 60, 1089-1902.
8. CLARKE SEM, LAZARUS CR, WRAIGHT P, SAMPSON C AND MAISEY MN. (1988). Pentavalent (99mTc)DMSA, (131I)MIBG, and (99mTc)MDP: an evaluation of three imaging technique in patients with medullary carcinoma of the thyroid. J. Nucl. Med., 29, 33 - 38.
9. CHARKES ND, VITTI RA AND BROOKS K. (1990). Thallium-201 SPECT increases detectability of thyroid cancer metastases. J. Nucl. Med., 31, 147 153.
10. CHONG GC, BEAHRS OH, SIZEMORE GW AND WODNER LH. (1975). Medullary carcinoma of the thyroid gland. Cancer, 35, 695-704.
11. COLOMBO P, PAGANELLI G, MAGNANI P, SONGINI C, FAZIO F AND FAGLIA G. (1993). Immunoscintigraphy with anti-chromogranin A antibodies in patients with endocrine/neuroendocrine tumors. J. Endocrinol. Invest., 16, 841-843.
12. CROW JP, AZAR-KIA B AND PRINZ RA. (1989). Recurrent occult medullary thyroid carcinoma detected by MR imaging. Am. J. Roentgenol., 152, 1255-1256.
13. DE LELLIS RA, RULE AH, SPILER I, NATHANSON L, TASHJIAN AH AND WOLFE HJ. (1978). Calcitonin and carcinoembryonic antigen as tumour markers in medullary thyroid carcinomas. Am. J. Clin. Pathol., 70, 587 594.
14. DOMOGATSKY SP. (1989). Rapid blood clearance of biotinylated IgG after infusion of avidin. J. Nucl. Med., 30, 66-69.
15. DOSIO F, MAGNANI P, PAGANELLI G, SAMUEL A, CHIESA G AND FAZIO F. (1994). Three-step tumour pretargeting in lung cancer. J. Nucl. Biol. Med., 37, 228-233.
16. EDINGTON HD, WATSON CG AND LEVINE G. (1988). Radioimmunoimaging of metastatic medullary carcinoma of the thyroid gland using an indium-111 labelled monoclonal antibody to CEA. Surgery, 104, 1004-1010.
17. FAZIO F AND PAGANELLI G. (1993). Antibody-guided scintigraphy: targeting the 'magic bullet'. Eur. J. Nucl. Med., 20, 1138-1140.
18. FLEISS JE. (1980). The measurement of interrater agreement. In Statistical Methods for Rates and Proportions, pp. 212 -236, J Wiley and Sons: New York.
19. FRANK K, RAUE F, LORENZ D, HEFARTH C AND ZIEGLER R. (1987). Importance of ultrasound examination for the follow-up of medullary thyroid carcinoma: comparison with other localization methods. Henry Ford Hosp. Med. J., 35, 122-123.
20. GASPARINI M, RIPAMONTI M, SEREGNI E, REGALIA E AND BURAGGI GL. (1988). Tumour imaging of colo-rectal carcinoma with an anti-CEA monoclonal antibody. Int. J. Cancer, (Suppl. 2), 81 84.
21. GOLDENBERG DM, KIM EE, DELAND FH, BENNET S AND PRIMUS FJ. (1980). Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res., 40, 2984-2992.
22. GOODWIN DA, MEARES CF, MCCALL MJ, MCTIGUE M AND CHAOVAPONG W. (1988). Pre-targeted immunoscintigraphy of murine tumours with indium-111-labelled bifunctional haptens. J. Nucl. Med., 29, 226-234.
23. GUERRA UP, PIZZOCARO C, TERZI A, GIUBBINI R, MAIRA G, PAGLIAINI R AND BESTAGNO M. (1989). New tracers for the imaging of the medullary thyroid carcinoma, Nucl. Med. Commun., 10, 285-295.
24. HILDITCH TE. (1987). Technetium-99m(V)-DMSA in the imaging of medullary thyroid carcinoma. J. Nucl. Med., 28, 253.
25. HILDITCH TE, CONNEL JMC, ELLIOT AT, MURRAY T AND REED NS. (1986). Poor results with technetium-99m(V) DMSA and iodine-131 MIBG in the imaging of medullary thyroid carcinoma. J. Nucl. Med., 27, 1150-1153.
26. HNATOWICH DJ, VIRZI F AND RUSCKOWSKI M. (1987). Investigation of avidin and biotin for imaging applications. J. Nucl. Med., 28, 1294-1302.
27. HOEFNAGEL CA, DELPRAT CC, ZANIN D AND VAN DER SCHOOT JB. (1988). New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma. Clin. Nucl. Med., 13, 159-165.
28. KALOFONOS HP, RUSCKOWSKI M, SIEBECKER DA, SIVOLAPENKO GB, SNOOK D, LAVENDER JP, EPENETOS AA AND HANTOWICH DJ. (1990). Imaging of tumour in patients with Indium-111-labelled biotin and streptavidin-conjugated antibodies: preliminary communications. J. Nucl. Med., 31, 1791-1796.
29. LARSON MS. (1985). Radiolabelled monoclonal anti-tumour antibodies in diagnosis and therapy. J. Nucl. Med., 26, 538-545.
30. LE DOUSSAL JM, MARTIN M, GAUTHEROT E, DELAAGE M AND BARBET J. (1989). In vitro and in vivo targeting of radiolabelled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate. J. Nucl. Med., 30, 1358-1366.
31. MANIL L, BOUDET F, MOTTE P, GARDET P, SACCAVINI JC, LUMBROSO JD, SCHLUMBERGER M, CAILLOU B, BAZIN JP, RICARD M, BELLET D, BOHUON C. TUBIANA M, DI PAOLA R AND PARMENTIER C. (1989). Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma. Cancer Res., 49, 5480-5485.
32. MATZKU S, KIRCHGESSNER H, SCHMID U, TEMPONI M AND FERRONE S. (1989). Melanoma targeting with a cocktail of monoclonal antibodies to distinct determinants of the human HMW-MAA. J. Nucl. Med., 30, 390-397.
33. 99mTc](V)DMSA scintigraphy in patients with medullary carcinoma of the thyroid. J. Nucl. Med., 30, 1420.
34. 111in-labelled anti-CEA monoclonal antibody fragments. Nucl. Med. Commun., 13, 142-148.
35. PACINI F, BASOLO F AND ELISEI R. (1991). Medullary thyroid cancer: an immunohistochemical and tumoural study using six separate antigens. Am. J. Clin. Pathol., 95, 300-308.
36. PAGANELLI G, MAGNANI P, ZITO F, VILLA E, SUDATI F, LOPALCO L, ROSSETTI C, MALCOVATI M, CHIOLERIO F, SECCAMANI E, SICCARDI AG AND FAZIO F. (1991). Three-step monoclonal antibody tumour targeting in carcinoembryonic antigen-positive patients. Cancer Res., 51, 5960-5966.
37. 99mTc)PnAo-biotin. Eur. J. Nucl. Med., 21, 314-321.
38. PAGANELLI G, SONGINI C, MAGNANI P, SAMUEL A, DI LEO C, SUDATI F, SIDOLI S, SICCARDI AG AND FAZIO F. (1994b). Pre-targetted immunoscintigraphy with the avidin/biotin system: four years experience. J. Nucl. Med., 35, 55P.
39. PELAGI M, BISIANI C, GINI A AND BONARDI MA. (1989). Preparation and characterization of an anti-human chromogranin A and chromogranin B (secretogranin I) monoclonal antibodies. Mol. Cell Probes, 3, 87-101.
40. PELTIER P, CURTET C, CHATAL JF, LE DOUSSAL JM, DANIEL G, AILLET G, GRUAZ-GUYON A, BARBET J AND DELAAGE M. (1993). Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-Indium-DTPA antibody and an Indium-111-labelled DTPA dimer. J. Nucl. Med., 34, 1267-1273.
41. 111in-labelled monoclonal anti-CEA antibody fragment. Med. Nucl., 25, 227-231.
42. ROSSI RL, MEISSNER WA, WOD MS, SEDGWICK CE AND WERVER J. (1980). Nonfamilial medullary thyroid carcinoma. Am. J. Surg., 139, 554-560.
43. ROUGIER P, PARMENTIER C AND LAPLANCHE A. (1983). Medullary thyroid carcinoma: prognostic factors and treatment. Int. J. Radiat. Oncol. Biol. Physiol., 9, 161-169.
44. ROWLINSON G, RUSCKOWSKI M, GIONET M, SIEBECKER D, SNOOK D, EPENETOS AA AND HNATOWICH DJ. (1988). Animal tumour localization studies with streptavidin conjugated antibody and labelled biotin. J. Nucl. Med., 29, 762.
45. SAMAAN NA, SCHULTZ PA AND HICKEY RC. (1988). Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy. J. Clin. Endocrinol. Metab., 67, 8801-8805.
46. SCHMID KW, FISCHER-COLBRIE R, HAGN C, JASANI B, WILLIAMS ED AND WINKLER H. (1987). Chromogranin A and B and secretogranin II in medullary carcinomas of thyroid. Am. J. Surg. Pathol. 11, 551-556.
47. SCHWERK WB, GRUN R AND WAHL R. (1985). Ultrasound diagnosis of C-cell carcinoma of the thyroid. Cancer, 55, 624-630.
48. SECCAMANI E, TATTANELLI M, MARIANI M, SPRANZI E, SCASSELLATI GA AND SICCARDI AG. (1989). A simple qualitative determination of human antibodies to murine immunoglobulins (HAMA) in serum samples. Nucl. Med. Biol., 2, 167-170.
49. 2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicenter study. Cancer Res., 49, 3095-3103.
50. TALERMAN A, LINDEMAN J, KIEVIT-TYSON PA AND DROGE-DROPPERT C, (1979). Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MTC) by immunoperoxidase technique. Histopathologv, 3, 503-510.
51. UDELSMAN R, BALL D, BAYLIN SB, WONG CY, OSTERMAN FA, AND SOSTRE S. (1993). Preoperative localization of occult medullary carcinoma of the thyroid gland with single-photon emission tomography dimercaptosuccinic acid. Surgery, 114, 1083-1089.
52. 2 fragments of anti-carcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma. J. Clin. Endocrinol. Metab., 74, 157-163.
53. ZANIN DEA, VAN DONGEN A, HOEFNAGEL CA AND BRUNING PF. (1990). Radioimmunoscintigraphy using iodine-131 anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report. J. Nucl. Med., 31, 1854-1855.